Anterix Inc.
ATEX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 9.4% | 2.1% | -11.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 3,942.5% | -821.2% | -756.9% | -642.8% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 3,449.5% | 1,775.7% | 662.9% | 492.3% |
| EPS Diluted | 2.86 | 1.35 | 0.49 | 0.41 |
| % Growth | 111.9% | 175.5% | 19.5% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |